CFO4Life Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-429
| Closed | -$213K | – | 244 |
|
|
2025
Q1 | $213K | Sell |
429
-2
| -0.5% | -$995 | 0.04% | 198 |
|
|
2024
Q4 | $224K | Buy |
431
+17
| +4% | +$8.84K | 0.04% | 190 |
|
|
2024
Q3 | $256K | Sell |
414
-2
| -0.5% | -$1.24K | 0.05% | 173 |
|
|
2024
Q2 | $230K | Buy |
416
+14
| +3% | +$7.74K | 0.04% | 174 |
|
|
2024
Q1 | $234K | Buy |
+402
| New | +$234K | 0.04% | 166 |
|
|
2023
Q3 | – | Sell |
-1,582
| Closed | -$825K | – | 182 |
|
|
2023
Q2 | $825K | Sell |
1,582
-40
| -2% | -$20.9K | 0.18% | 64 |
|
|
2023
Q1 | $935K | Buy |
1,622
+54
| +3% | +$31.1K | 0.21% | 52 |
|
|
2022
Q4 | $864K | Sell |
1,568
-212
| -12% | -$117K | 0.18% | 66 |
|
|
2022
Q3 | $903K | Buy |
1,780
+312
| +21% | +$158K | 0.24% | 48 |
|
|
2022
Q2 | $764K | Sell |
1,468
-71
| -5% | -$37K | 0.19% | 57 |
|
|
2022
Q1 | $909K | Buy |
1,539
+6
| +0.4% | +$3.54K | 0.19% | 55 |
|
|
2021
Q4 | $1.02M | Buy |
1,533
+108
| +8% | +$72.1K | 0.21% | 54 |
|
|
2021
Q3 | $814K | Buy |
1,425
+171
| +14% | +$97.7K | 0.19% | 61 |
|
|
2021
Q2 | $633K | Buy |
1,254
+32
| +3% | +$16.2K | 0.15% | 72 |
|
|
2021
Q1 | $558K | Buy |
1,222
+6
| +0.5% | +$2.74K | 0.14% | 79 |
|
|
2020
Q4 | $567K | Buy |
1,216
+22
| +2% | +$10.3K | 0.16% | 71 |
|
|
2020
Q3 | $527K | Buy |
1,194
+280
| +31% | +$124K | 0.18% | 62 |
|
|
2020
Q2 | $331K | Sell |
914
-663
| -42% | -$240K | 0.13% | 84 |
|
|
2020
Q1 | $447K | Sell |
1,577
-87
| -5% | -$24.7K | 0.24% | 57 |
|
|
2019
Q4 | $540K | Sell |
1,664
-41
| -2% | -$13.3K | 0.23% | 65 |
|
|
2019
Q3 | $497K | Sell |
1,705
-239
| -12% | -$69.7K | 0.22% | 67 |
|
|
2019
Q2 | $571K | Buy |
1,944
+2
| +0.1% | +$587 | 0.26% | 61 |
|
|
2019
Q1 | $532K | Buy |
+1,942
| New | +$532K | 0.25% | 61 |
|